Latest Insider Transactions at Zim Vie Inc. (ZIMV)
This section provides a real-time view of insider transactions for Zim Vie Inc. (ZIMV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ZimVie Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ZimVie Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Sally Crawford Director |
BUY
Open market or private purchase
|
Direct |
40,000
+49.92%
|
$200,000
$5.6 P/Share
|
|
Mar 10
2023
|
Sandra Schneider Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
843
-23.47%
|
$4,215
$5.5 P/Share
|
|
Mar 10
2023
|
Sandra Schneider Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,592
+50.0%
|
-
|
|
Mar 10
2023
|
Heather Kidwell Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
764
-1.61%
|
$3,820
$5.5 P/Share
|
|
Mar 10
2023
|
Heather Kidwell Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,776
+5.52%
|
-
|
|
Mar 10
2023
|
Heather Kidwell Officer |
BUY
Open market or private purchase
|
Direct |
36,765
+45.1%
|
$183,825
$5.55 P/Share
|
|
Mar 10
2023
|
Rebecca Ann Whitney Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,198
-10.08%
|
$5,990
$5.5 P/Share
|
|
Mar 10
2023
|
Rebecca Ann Whitney Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,164
+25.94%
|
-
|
|
Mar 10
2023
|
Richard Heppenstall Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,690
-3.69%
|
$8,450
$5.5 P/Share
|
|
Mar 10
2023
|
Richard Heppenstall Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,939
+13.17%
|
-
|
|
Mar 10
2023
|
Vafa Jamali Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,985
-3.79%
|
$29,925
$5.5 P/Share
|
|
Mar 10
2023
|
Vafa Jamali Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,817
+11.64%
|
-
|
|
Mar 10
2023
|
Indraneel Kanaglekar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,014
-9.38%
|
$5,070
$5.5 P/Share
|
|
Mar 10
2023
|
Indraneel Kanaglekar Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,164
+27.81%
|
-
|
|
Mar 09
2023
|
Vafa Jamali Director |
BUY
Open market or private purchase
|
Direct |
20,000
+12.72%
|
$100,000
$5.58 P/Share
|
|
Mar 06
2023
|
Vafa Jamali Director |
BUY
Open market or private purchase
|
Direct |
20,000
+14.57%
|
$120,000
$6.1 P/Share
|
|
Mar 06
2023
|
Richard Heppenstall Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+24.36%
|
$75,000
$6.0 P/Share
|
|
Mar 01
2023
|
Vafa Jamali Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,937
-3.89%
|
$39,370
$10.74 P/Share
|
|
Feb 21
2023
|
Heather Kidwell Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
550
-5.71%
|
$6,050
$11.39 P/Share
|
|
Feb 21
2023
|
Rebecca Ann Whitney Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
974
-9.15%
|
$10,714
$11.39 P/Share
|
|
Feb 21
2023
|
Indraneel Kanaglekar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-5.37%
|
$4,675
$11.39 P/Share
|
|
Feb 01
2023
|
Zimmer Biomet Holdings, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,131,946
-100.0%
|
$46,187,514
$9.57 P/Share
|
|
Oct 01
2022
|
Richard Heppenstall Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,058
-3.87%
|
$10,580
$10.04 P/Share
|
|
Oct 01
2022
|
David John Harmon Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-6.16%
|
$1,070
$10.04 P/Share
|
|
Jul 01
2022
|
Indraneel Kanaglekar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
147
-2.31%
|
$2,352
$16.16 P/Share
|
|
May 10
2022
|
Richard Heppenstall Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+26.76%
|
$200,000
$20.45 P/Share
|
|
May 10
2022
|
Vafa Jamali Director |
BUY
Open market or private purchase
|
Direct |
10,000
+9.09%
|
$200,000
$20.04 P/Share
|
|
Mar 09
2022
|
Vafa Jamali Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,960
-4.21%
|
$91,080
$23.11 P/Share
|
|
Mar 01
2022
|
Vafa Jamali Director |
BUY
Grant, award, or other acquisition
|
Direct |
93,975
+43.41%
|
-
|
|
Mar 01
2022
|
David John Harmon Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+50.0%
|
-
|
|
Mar 01
2022
|
Heather Kidwell Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,055
+36.7%
|
-
|
|
Mar 01
2022
|
Indraneel Kanaglekar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,207
+37.44%
|
-
|
|
Mar 01
2022
|
Richard Heppenstall Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,366
+50.0%
|
-
|
|
Mar 01
2022
|
Rebecca Ann Whitney Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,314
+42.73%
|
-
|
|
Mar 01
2022
|
Zimmer Biomet Holdings, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
20,918,542
-80.3%
|
-
|